PT-141 10mg Australia | Silverback Peptides – Research Use Only

PT-141 (Bremelanotide) 10mg is a synthetic peptide supplied by Silverback Peptides for laboratory, scientific, and investigational research. PT-141 is a melanocortin receptor agonist that has been studied for its interaction with melanocortin signalling pathways, including MC3R and MC4R.

This research peptide is supplied as a lyophilised powder and is intended exclusively for controlled laboratory research. It is not supplied for human or veterinary use.

PT-141 10mg Research Overview

PT-141, also known as bremelanotide, is a synthetic cyclic peptide derived from melanocortin research. Scientific studies have investigated its activity at melanocortin receptors and associated signalling pathways.

Researchers may use PT-141 in experimental studies examining:

• Melanocortin receptor signalling
• MC3R and MC4R activity
• Peptide-receptor interactions
• Central nervous system signalling pathways
• GPCR-related research
• Structure–activity relationship studies involving melanocortin peptides

Product Specifications

• Product: PT-141 / Bremelanotide
• Quantity: 10mg
• Form: Lyophilised powder
• Use: Laboratory and scientific research only
• Brand: Silverback Peptides
• Country: Australia

Research Use Only

PT-141 10mg is provided strictly as a research compound. It is not intended for consumption, diagnosis, treatment, prevention, or management of any disease or medical condition.

Silverback Peptides products are intended for qualified researchers and laboratory applications where appropriate handling, storage, and experimental protocols are followed.

For laboratory research only. Not for human or veterinary use.